Curetis Initiates Next Phase of Unyvero U.S. FDA Trial in Lower Respiratory Tract Infections

World News: . []

HOLZGERLINGEN Germany July 8 2015 GLOBE NEWSWIRE -- LINK  AG a developer of next-level molecular diagnostic LINK  today announced the enrollment of the first patient in the prospective phase of its LINK  US FDA trial The primary endpoi...

More news and information about Curetis AG

Published By:

Globe Newswire: 15:39 GMT Wednesday 8th July 2015

Published: .

Search for other references to "curetis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us